Dr Deborah Von Bolschwing, PHD in Dillon Beach, CA - Psychologist

Dr Deborah Von Bolschwing, PHD is a Psychologist based in Dillon Beach, California. Dr Deborah Von Bolschwing is licensed to practice in California (license number PSB355039) and her current practice location is 576 Oceana Drive, Dillon Beach, California. She can be reached at her office (for appointments etc.) via phone at (707) 878-2446.

NPI number for Dr Deborah Von Bolschwing is 1194989053 and her current mailing address is Po Box 84, 576 Oceana Drive, Dillon Beach, California. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1194989053.

Contact Information

	Dr Deborah Von Bolschwing, PHD
	576 Oceana Drive, Dillon Beach, CA 94929
	(707) 878-2446
	Not Available

Healthcare Provider's Profile

Full Name	Dr Deborah Von Bolschwing
Gender	Female
Speciality	Psychologist
Location	576 Oceana Drive, Dillon Beach, California
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1194989053
Provider Enumeration Date: 07/10/2008
Last Update Date: 07/10/2008

Medical Identifiers

Medical identifiers for Dr Deborah Von Bolschwing such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1194989053	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
103T00000X	Psychologist	PSB355039 (California)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Deborah Von Bolschwing is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Deborah Von Bolschwing, PHD Po Box 84, 576 Oceana Drive, Dillon Beach, CA 94929 Ph: (707) 878-2446	Dr Deborah Von Bolschwing, PHD 576 Oceana Drive, Dillon Beach, CA 94929 Ph: (707) 878-2446

News Archive

Cardiac CTA parameters predict mortality after transcatheter aortic valve replacement

According to ARRS' American Journal of Roentgenology (AJR), cardiac CTA-derived left atrium emptying fraction (LAEF) improves predictive performance of established clinical risk scores and may be used to assess patients' risk during pre-transcatheter aortic valve replacement (TAVR) workup and postprocedural surveillance.

NQF implements quality measures pertaining to ambulatory emergency and urgent care

To improve healthcare quality and give patients and providers more information about the results of care, the National Quality Forum has endorsed 16 ambulatory care measures, with a particular focus on emergency and urgent care.

Timing of carbohydrate intake plays role in blood glucose regulation for men with prediabetes

According to a nutrition study led by the German Institute of Human Nutrition, a partner of the German Center for Diabetes Research, the so-called internal clock also influences how people with impaired glucose metabolism react to carbohydrate-rich food.

Surgical patients with chronic psychological symptoms require psychotherapeutic treatment

In their study, the research group, headed by Privatdozent Dr. Henning Krampe, psychologist at the Charité Department of Anesthesiology and Intensive Care Medicine, Prof. Claudia Spies, Director of the Charité Department of Anesthesiology and Intensive Care Medicine and Prof. Elmar Brähler, Head of the Department of Medical Psychology and Medical Sociology at the University of Leipzig, initially recorded how many patients faced by a forthcoming operation were interested in psychotherapy sessions and to what extent this interest was associated with the increased psychological distress occurring before the operation. Finally, the scientists examined whether changes in the psychological symptoms took place during the six months following the surgery.

Medicinal chemistry paper related to the discovery of CUDC-101 published

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that a medicinal chemistry paper related to the discovery of CUDC-101, Curis's HDAC, EGFR and Her2 inhibitor, was published online in the Journal of Medicinal Chemistry and also will be published in an upcoming print version of the journal.

Dr Deborah Von Bolschwing, PHD - Psychologist in Dillon Beach, CA